Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
Two papers providein vivoevidence for plasticity of epithelial and mesenchymal transitions, showing that EMT reversion is required for metastatic outgrowth.
Joan Massagué and colleagues have found that epigenetic changes contribute to metastasis in clear-cell renal-cell carcinomas in which the tumour suppressor gene von Hippel–Lindau (VHL) is inactivated.
As we begin 2013 it's time to take stock of what we do know and what we don't, and consider how best to approach finding new treatments for cancer. Do we embrace complexity or go back to basics?
This Review highlights the complexity and context-dependent roles of both β-catenin-dependent and β-catenin-independent WNT signalling pathways in cancer, as well as some of the ways in which WNT signalling might be targeted therapeutically.
Using theDrosophila melanogastermidgut as a model of intestinal hyperproliferation, Julia Cordero, Owen Sansom and colleagues have identified non-cell-autonomous crosstalk among WNT–MYC, EGFR and JAK–STAT signalling pathways downstream of APC loss; importantly, this pathway may also operate in human colorectal tumours.
A new study shows how angiogenesis may be controlled by epsin proteins, the targeting of which can result in a tumour-suppressive form of angiogenesis.
